跳至主要内容
临床试验/CTRI/2021/02/031256
CTRI/2021/02/031256已完成2 期

Clinical validation of safety & efficacy of Madhav Rasayan Plus in subjects of COVID 19. - Nil

Shree Vishwavati Ayurvedic Chikitsalaya and Research Centre0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age -18- 60 years (Both sex)
  • Confirmed COVID 19 patient with positive RT-PCR
  • Moderate to severe symptomatic patients having no signs of ARDS (NEWS score <=8)
  • Subject willing to provide consent and follow up for study duration

排除标准

  • Patients with autoimmune disease or self-reports HIV or syphilis infection
  • Proves to be unfit for the study as per the investigatorâ??s discretion
  • Pregnant or lactating women
  • Requiring ICU admission at screening
  • Any other comorbidity which is critical stage at screening which in investigator discretion finds subject not suitable for the trial participation

研究者

发起方
Shree Vishwavati Ayurvedic Chikitsalaya and Research Centre

相似试验